Across most of the United States, a closely related family of JN lineages is now driving the majority of new COVID infections.1-lineage subvariants, primarily LP.8.1 and XEC, that typically begin with a sore throat and dry cough. Fever tends to stay modest, fatigue lingers, and loss of taste or smell rarely shows up. SARS-CoV-2 has not settled into a predictable seasonal rhythm, so a short wave can hit in summer as easily as winter.
This practical walkthrough covers today’s circulating JN.1-lineage variants, what their symptoms actually feel like in 2025, and how to read local transmission data, test smartly, and follow current isolation and booster guidance.
The COVID Variants Circulating Now and How They Are Tracked
SARS-CoV-2 keeps producing new subvariants because the virus mutates each time it copies itself inside a cell. Most changes do nothing useful. Occasionally, a tweak to the spike protein helps the virus dodge antibodies from prior infection or vaccination, and that descendant outcompetes its relatives. Nearly every lineage spreading at scale today descends from JN.1, the Omicron offshoot that dominated the winter of 2023-2024.
LP.8.1, XEC, and Other JN.1 Descendants Lead the Pack
Early 2025 belongs to a small family of JN.1-derived strains. LP.8.1 and XEC sit near the top of prevalence charts, with KP.3 and a handful of related lineages filling out the field. None of these represent a brand-new branch of the family tree, which matters clinically because immune protection from prior infection and from the 2024-2025 vaccines still lands on them with reasonable force.
Public dashboards estimate which lineages are rising before full genomic sequencing catches up. CDC’s Nowcast tool models variant proportions using a mix of reported sequences and machine learning, projecting which strains will dominate two to four weeks ahead. When Nowcast shifts toward a new lineage, hospital labs and wastewater monitoring usually confirm the trend within days.
Wastewater Surveillance Reveals What Clinics Miss
Reported case counts have fallen sharply because most people test at home and never report results. Wastewater data closes that gap. Sewersheds across the country, coordinated through CDC’s National Wastewater Surveillance System, measure SARS-CoV-2 RNA concentration in sewage and publish weekly trends by county and region.
Rising wastewater activity typically predicts a clinical surge by one to two weeks. When the trend curve bends upward in your region, expect more infections, more missed workdays, and more chances of bringing the virus home. A plateau at low levels signals community spread has quieted. A sharp climb over seven to ten days suggests a wave is forming.
| Signal | Where to Find It | What It Tells You |
|---|---|---|
| Nowcast projections | CDC COVID Data Tracker, variant tab | Which lineage is rising before sequencing confirms it |
| Wastewater activity | CDC Wastewater Dashboard by state | True community spread 1–2 weeks ahead of cases |
| Hospital admissions | CDC respiratory disease dashboard | Severity of the current wave by region |
| Test positivity | Regional public health labs | Share of tests coming back positive |
Read wastewater as a trend, not a single number. A week-over-week rise matters far more than the absolute level on any given day.
What Current COVID Symptoms Actually Feel Like in 2025
Walk into any urgent care during a current wave and the intake board looks familiar. Sore throat, dry cough, congestion, fatigue, and a low-grade fever top the list. Most people describe it as a cold that drags, with tiredness lasting a week or more even after other symptoms fade.
The Symptom Profile Defining JN.1-Lineage Infections
Across multiple tracking studies, the same five symptoms dominate. Sore throat comes first for many adults, often before a positive test would register. Cough follows within a day or two, usually dry and persistent. Congestion can rival a sinus infection. Fatigue settles in early and lingers. Fever, when present, tends to stay modest, in the 99 to 101°F range, though higher spikes do happen.
Loss of taste and smell has become uncommon. During the original 2020 wave and the Delta surge in 2021, that symptom appeared in 40 to 60 percent of cases. Today, reported rates sit closer to 5 to 10 percent, likely because Omicron descendants replicate less aggressively in the olfactory nerves.
How COVID Overlaps With Flu, RSV, and Allergies
The symptom overlap with other respiratory viruses is the main reason testing matters. Flu tends to hit harder and faster, with sudden high fever, body aches, and chest discomfort. RSV in adults usually looks like a cold but can spark wheezing in kids and older adults. Seasonal allergies bring itching, watery eyes, and sneezing without fever or deep fatigue.
| Symptom | COVID | Flu | RSV | Allergies |
|---|---|---|---|---|
| Sore throat | Very common | Common | Sometimes | Rare |
| Dry cough | Very common | Common | Common | Occasional |
| Fatigue | Common, lingering | Common, resolves faster | Mild | Rare |
| Fever | Low to moderate | High, sudden | Low in adults | Never |
| Loss of taste/smell | Uncommon now | Rare | Rare | Never |
| Itchy eyes, sneezing | Rare | Rare | Rare | Hallmark |
For most adults, the first 48 hours unfold with a sore throat, mild body aches, and growing tiredness. Children often show congestion and a cranky mood before cough or fever appear. If fatigue or brain fog stretches past four weeks without improvement, the pattern deserves attention. Long COVID can emerge even after a mild initial infection, and recognizing it early helps you access the right follow-up care.
Reading Local Transmission Levels Without Misreading the Numbers
Hospital admissions and wastewater data now carry more weight than headline case counts. Both capture spread across a whole community, including the people who test at home or skip testing altogether. Combining the two gives the clearest picture of what is happening in your county right now.
Why Hospital Admissions and Wastewater Lead the Signal
Hospitalization rates lag infection by about two weeks but reflect real clinical severity. When admissions rise, the wave is meaningful, not just a bump in mild cases. Wastewater shows the wave forming earlier. Together they tell a complete story: wastewater warns, hospitalizations confirm.
Summer and winter waves have become the new normal. SARS-CoV-2 no longer disappears between waves. It circulates at low levels year-round, then surges when weather drives people indoors or when immune escape tips a new subvariant into dominance. Expect two distinct bumps on the annual curve, one around late December through February and another in mid-to-late summer.
How to Translate Local Data Into Personal Risk
Start with the CDC wastewater dashboard for your state or territory. Look at the trend line for your sewershed over the past four weeks rather than the absolute value on any single day. Pair that with regional hospital admission rates from the CDC respiratory dashboard. A reasonable personal-risk scale looks like this:
Knowing which virus is driving local spread is only half the picture; the other half is confirming what is actually making you sick.
- Low: wastewater flat or declining, hospital admissions under 2 per 100,000. Routine precautions apply.
- Moderate: wastewater trending up for two consecutive weeks, admissions between 2 and 5 per 100,000. Mask in crowded indoor spaces if you live with a vulnerable person.
- High: wastewater sharply elevated and admissions above 5 per 100,000. Postpone non-essential indoor gatherings, mask in public, and test at the first symptom.
Testing Smart When Symptoms Could Be COVID, Flu, or RSV
A single negative rapid test does not rule out COVID, and a positive one does not tell you whether flu or RSV is also in play. The right testing strategy depends on your symptoms, your risk profile, and what is circulating locally.
At-Home Antigen Tests Still Work, With Caveats
Most rapid antigen tests on pharmacy shelves in 2025 detect current JN.1-derived variants. The proteins they target have not shifted enough to escape detection. Sensitivity can slip slightly with the newest subvariants, especially early in infection when viral load is low. Repeat testing matters: a second rapid test 24 to 48 hours after a negative result, taken when symptoms are still present, can flip the answer.
Combination tests that screen for COVID plus influenza A and B are widely sold and worth the extra cost when both viruses are peaking at once. A single nasal swab run at home can clarify whether the sore throat is COVID, flu, or something else entirely.
When PCR Still Earns Its Place
PCR testing remains the gold standard for sensitivity and matters in specific situations. High-risk patients often need a confirmed positive to access timely care. PCR can also confirm a negative rapid result when symptoms strongly suggest COVID. For long COVID workups, a documented prior infection, ideally with PCR confirmation, strengthens the diagnostic picture.
The right testing order during a multi-virus season looks like this:
- Symptom onset: rapid antigen test for COVID, ideally a combination kit covering flu A and B.
- Day 2, still negative: repeat the rapid test. False negatives happen when viral load is still climbing.
- High-risk patient or persistent symptoms: schedule a PCR test through a clinic or pharmacy.
- Hospitalization or severe illness: full respiratory panel at the hospital to identify the exact pathogen.
Current Isolation, Treatment, and Booster Guidance That Actually Applies
Three things have shifted since the early pandemic: vaccines target current subvariants, antivirals are widely available for at-risk groups, and isolation rules have been simplified. Each update reduces the guesswork when symptoms hit.
The 2024-2025 mRNA Vaccines Target JN.1 Derivatives
Updated mRNA vaccines from Pfizer-BioNTech and Moderna were formulated against JN.1-derived subvariants and authorized for the fall and winter season. CDC recommends them for everyone six months and older, with stronger emphasis on adults 65 and older, people with weakened immune systems, pregnant people, and anyone with chronic conditions that raise COVID risk.
A booster received in the past four to six months restores meaningful protection against severe illness, even when it does not always block mild infection.
Antiviral Access and Who Qualifies
Oral antivirals such as Paxlovid remain available by prescription and work best when started within five days of symptom onset. Eligibility hinges on age, underlying conditions, and immune status rather than test severity. Adults 50 and older, people with chronic heart, lung, kidney, or liver disease, immunocompromised individuals, and pregnant people qualify more easily. A primary care clinician or pharmacist can confirm eligibility within a telehealth visit.
Isolation Rules and Masking in Practice
Updated guidance recommends staying home until fever has been gone for at least 24 hours without fever-reducing medication and symptoms are improving. For the next five days, masking in indoor public spaces and around high-risk household members reduces the chance of passing the virus on. Hospitalization rates in the U.S. have stayed comparatively low against the 2020 to 2022 peaks, but that does not mean individual risk has vanished.
Lower population risk does not cancel out personal vulnerability, especially for older adults and the immunocompromised.
Masking matters most in shared indoor air with people outside your household. A well-fitted N95 or KN95 still offers strong protection during a local surge.
A Practical Action Plan for the Next Time Symptoms Hit
Knowing what to do in the first 24 hours after symptoms start can change the entire course of an infection. Early testing, prompt isolation, and timely treatment access all depend on acting quickly. Below is a decision tree you can save and follow.
From First Symptom to Recovery: A Step-by-Step Path
- Test at first sign: scratchy throat, fatigue, or mild fever calls for an immediate rapid antigen test, ideally a combination COVID and flu kit.
- Isolate while awaiting results: stay home from work, school, and social plans until you know what you are dealing with.
- Confirm with a second test if needed: a negative result 24 hours into symptoms deserves a repeat rapid test 48 hours in.
- Notify close contacts: anyone you saw in the 48 hours before symptoms should be told so they can monitor and test.
- Talk to a clinician about antivirals: if you are in a high-risk group and test positive, contact your primary care provider or a telehealth service within the first five days.
- Monitor for warning signs: trouble breathing, persistent chest pain, confusion, inability to stay hydrated, or bluish lips all require emergency care.
- Return to routine gradually: resume normal activities once fever is gone for 24 hours and symptoms are clearly improving, masking around others for five more days.
Special Situations: Households With Vulnerable Members
Living with an elderly relative, an immunocompromised family member, or a pregnant person changes the math. Mask at home in shared spaces, sleep separately if possible, and open windows for ventilation. The infected person should isolate in one room with a dedicated bathroom if the home layout allows. School and workplace policies vary, but most districts and employers follow CDC guidance on return-to-school and return-to-work timelines.
Watch for urgent symptoms at any age: shortness of breath at rest, dehydration so severe you cannot keep fluids down, chest pressure that does not resolve, or sudden confusion. Those signs point to the emergency room, not a telehealth visit.
All of that guidance collapses into a short checklist when symptoms actually arrive and decisions have to happen fast.
Bottom Line
COVID still circulates, still mutates, and still deserves attention when symptoms appear. Track wastewater and hospital admission trends in your area, recognize the sore-throat-first pattern of JN.1-lineage infections, test early and repeat if negative, and reach out to a clinician quickly if you qualify for antivirals. A short list of clear actions, repeated consistently, does more to protect you and the people around you than any single vaccine or medication on its own.
FAQ
What are the current COVID symptoms right now?
Current JN.1-lineage infections most often begin with a sore throat, followed by dry cough, congestion, fatigue, and a low-grade fever. Loss of taste and smell has become uncommon compared with the original and Delta waves.
Which COVID variant is dominant right now?
LP.8.1 and XEC, both descendants of the JN.1 Omicron lineage, lead prevalence in early 2025 according to CDC Nowcast projections. They are JN.1 derivatives rather than a brand-new branch of the family tree.
Is COVID going around in 2025?
Yes. SARS-CoV-2 continues to circulate year-round, with summer and winter waves now the typical pattern. Wastewater surveillance and hospital admission data show ongoing community transmission across most U.S. regions.
How long are you contagious with the new COVID strain?
Most people with current variants remain contagious for roughly 5 to 10 days after symptoms start, with the highest risk during the first few days. Immunocompromised individuals can shed virus longer and should follow clinician guidance.
Should I get another COVID booster this year?
CDC recommends the updated 2024-2025 mRNA vaccine for everyone six months and older, with priority for adults 65 and older, pregnant people, the immunocompromised, and anyone with chronic conditions that raise COVID risk.
Where can I find COVID case counts for my state?
The CDC COVID Data Tracker combines wastewater trends, hospital admissions, and test positivity by state and region. State and local health department dashboards often add county-level detail.
